These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11192857)

  • 21. Efavirenz + emtricitabine + tenofovir: new combination. HIV infection: do not modify ongoing therapy just to use one less tablet. Better adherence than with separate dosing has not been demonstrated, while reduced efficacy is plausible.
    Prescrire Int; 2009 Jun; 18(101):105. PubMed ID: 19637416
    [No Abstract]   [Full Text] [Related]  

  • 22. [Results of the AIDS-In-Europe Study. Non-nucleoside reverse transcriptase inhibitor does not equal non-nucleoside reverse transcriptase inhibitor].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():39. PubMed ID: 11373776
    [No Abstract]   [Full Text] [Related]  

  • 23. Efavirenz decreases methadone blood concentrations.
    Marzolini C; Troillet N; Telenti A; Baumann P; Decosterd LA; Eap CB
    AIDS; 2000 Jun; 14(9):1291-2. PubMed ID: 10894303
    [No Abstract]   [Full Text] [Related]  

  • 24. Indinavir/ritonavir 800/100 mg bid and efavirenz 600 mg qd in patients failing treatment with combination nucleoside reverse transcriptase inhibitors: 96-week outcomes of HIV-NAT 009.
    Boyd MA; Siangphoe U; Ruxrungtham K; Duncombe CJ; Stek M; Lange JM; Cooper DA; Phanuphak P
    HIV Med; 2005 Nov; 6(6):410-20. PubMed ID: 16268823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [HIV infection: DuPont Pharma presents the results of its antiretroviral agent].
    Allerg Immunol (Paris); 1998 Apr; 30(4):123-4. PubMed ID: 9631694
    [No Abstract]   [Full Text] [Related]  

  • 26. HIV-related neutropaenia exacerbated by efavirenz.
    Healy BJ; Freedman AR
    HIV Med; 2006 Mar; 7(2):129-31. PubMed ID: 16420258
    [No Abstract]   [Full Text] [Related]  

  • 27. Lipodystrophy associated with nevirapine-containing antiretroviral therapies.
    Aldeen T; Wells C; Hay P; Davidson F; Lau R
    AIDS; 1999 May; 13(7):865-7. PubMed ID: 10357391
    [No Abstract]   [Full Text] [Related]  

  • 28. Highly active antiretroviral treatment containing efavirenz or nevirapine and related toxicity in the TREAT Asia HIV Observational Database.
    Zhou J; Phanupak P; Kiertiburanakul S; Ditangco R; Kamarulzaman A; Pujary S;
    J Acquir Immune Defic Syndr; 2006 Dec; 43(4):501-3. PubMed ID: 17099317
    [No Abstract]   [Full Text] [Related]  

  • 29. Cortisol serum levels and their relationship to certain antiretroviral drugs.
    Collazos J; Ibarra S; Loureiro M
    Scand J Infect Dis; 2004; 36(6-7):480-2. PubMed ID: 15307572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Switch to efavirenz in a protease inhibitor-containing regimen.
    Knechten H; Stürner KH; Höhn C; Braun P
    HIV Clin Trials; 2001; 2(3):200-4. PubMed ID: 11590528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there cross-toxicity between nevirapine and efavirenz in subjects developing rash?
    Soriano V; Dona C; Barreiro P; González-Lahoz J
    AIDS; 2000 Jul; 14(11):1672-3. PubMed ID: 10983663
    [No Abstract]   [Full Text] [Related]  

  • 32. A manic episode associated with efavirenz therapy for HIV infection.
    Shah MD; Balderson K
    AIDS; 2003 Jul; 17(11):1713-4. PubMed ID: 12853762
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antiretroviral therapy. NNRTI (non-nucleoside reverse transcriptase inhibitor)].
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():14-6. PubMed ID: 10863304
    [No Abstract]   [Full Text] [Related]  

  • 34. A case of lipodystrophy after the initiation of zidovudine, lamivudine and efavirenz in an asymptomatic HIV-1-infected patient.
    Rickerts V; Bickel M; Tews J; Jacobi V; Staszewski S
    HIV Med; 2000 Jul; 1(3):164-5. PubMed ID: 11737346
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypersensitivity syndrome associated with efavirenz therapy.
    Bossi P; Colin D; Bricaire F; Caumes E
    Clin Infect Dis; 2000 Jan; 30(1):227-8. PubMed ID: 10619772
    [No Abstract]   [Full Text] [Related]  

  • 36. Efavirenz and retinal toxicity.
    Lewis A; Mitchell S
    Eye (Lond); 2002 Jan; 16(1):107. PubMed ID: 11913879
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of NNRTIs in antiretroviral combination therapy: an introduction.
    Nelson M
    Int J STD AIDS; 2001 Nov; 12 Suppl 4():1-2. PubMed ID: 11589821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efavirenz-induced psychosis.
    de la Garza CL; Paoletti-Duarte S; García-Martín C; Gutiérrez-Casares JR
    AIDS; 2001 Sep; 15(14):1911-2. PubMed ID: 11579266
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of NNRTIs in antiretroviral-experienced patients.
    Maggiolo F
    Int J STD AIDS; 2001 Nov; 12 Suppl 4():10-7. PubMed ID: 11589823
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiretroviral rounds. When success is a pain.
    Bartlett JG; del Rio C
    AIDS Clin Care; 2001 Aug; 13(8):74-5. PubMed ID: 11547461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.